US FDA Puts Hold on Gilead's Blood Cancer Therapy Trials

Gilead Sciences said on Wednesday the U.S. Food and Drug Administration had put a hold on trials testing the company's blood cancer drug following increased risk of patient...

Related Keywords

Bengaluru ,Karnataka ,India ,Eli Lilly ,Innovent Biologics ,Khushi Mandowara ,Sriraj Kalluvila ,Reuters ,Drug Administration ,Forty Seven Inc ,Gilead Sciences ,Breast Cancer ,Alignant Breast Neoplasm ,Breast Carcinoma ,Leukemia Leukaemia Blood Cancer ,Cancer ,Alignant Neoplasia ,Arcinoma ,Alignant Neoplasm ,Blood ,Myelodysplastic Syndrome Mds Myelodysplasia ,Breast ,Mammary Gland ,Chemotherapy ,